Quick Answer
STANDARD BIOTOOLS INC. reported Net Income of -$74.90 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$74.90M | +46.1% |
| 2024 | -$138.88M | -86.0% |
| 2023 | -$74.66M | +60.7% |
| 2022 | -$190.10M | -220.9% |
| 2021 | -$59.24M | -11.7% |
| 2020 | -$53.02M | +18.2% |
| 2019 | -$64.79M | -9.8% |
| 2018 | -$59.01M | +2.5% |
| 2017 | -$60.53M | +20.3% |
| 2016 | -$75.98M | -42.5% |
| 2015 | -$53.31M | -0.9% |
| 2014 | -$52.83M | -219.7% |
| 2013 | -$16.53M | +13.1% |
| 2012 | -$19.02M | +15.3% |
| 2011 | -$22.47M | -32.9% |
| 2010 | -$16.90M | +11.6% |
| 2009 | -$19.13M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$34.69M | -28.8% | -3.7% |
| June 30, 2025 | -$33.46M | +26.8% | -28.5% |
| March 31, 2025 | -$26.03M | +19.0% | +3.4% |
| September 30, 2024 | -$26.94M | -28.3% | +41.1% |
| June 30, 2024 | -$45.72M | -168.3% | -42.2% |
| March 31, 2024 | -$32.16M | -90.9% | -53.2% |
| September 30, 2023 | -$21.00M | +28.6% | -23.2% |
| June 30, 2023 | -$17.04M | +73.2% | -1.2% |
- STANDARD BIOTOOLS INC. showed an increase of +46.1% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, STANDARD BIOTOOLS INC.’s net income has declined by 291.6% (from -$19.13 million to -$74.90 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: